Applications of SGLT2 inhibitors beyond glycaemic control.
O'Hara DV, Lam CSP, McMurray JJV, Yi TW, Hocking S, Dawson J, Raichand S, Januszewski AS, Jardine MJ.
O'Hara DV, et al. Among authors: yi tw.
Nat Rev Nephrol. 2024 Apr 26. doi: 10.1038/s41581-024-00836-y. Online ahead of print.
Nat Rev Nephrol. 2024.
PMID: 38671190
Review.